Skip to main content

Science
Products
Stories
Newsroom
About

Investors Media Careers Partners

Careers
Investors

Changed

Changed

How can we help you?

0 search results for

Suggestions within Pfizer.com

Home
News
Press Releases

Press Release Archive

Press Releases

Year

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

Month

January

February

March

April

May

June

July

August

September

October

November

December

View 12

View 24

View 48

Categories

Corporate
Financial
Prescription Medicines
Research and Pipeline
Social Responsibility
Vaccines

Keywords

All Keywords

Covid-19
Finance
Investments
Leadership
Medicines
Partnerships
Research
Responsibility
Vaccines

August 2012

08.13.2012
Pfizer And Astrazeneca Enter Into Agreement For Over-The-Counter Nexium
- Partnerships
08.12.2012
Zoetis™ Files IPO Registration Statement
08.09.2012
Pfizer Reports Results From Phase 3 Study Of Torisel (temsirolimus) In Combination With Bevacizumab In Advanced Renal Cell Carcinoma (RCC)
08.09.2012
Nodality Enters into a Multi-Year Strategic Collaboration with Pfizer in Autoimmune Disease
- Partnerships
08.08.2012
Pfizer Reduces Its Greenhouse Gas Emissions by 20 Percent
08.07.2012
Pfizer Announces Resolutions with DOJ and SEC Related to Certain International Operations
08.06.2012
Pfizer Announces Co-Primary Clinical Endpoints Not Met In Second Phase 3 Bapineuzumab Study In Mild-To-Moderate Alzheimer’s Disease Patients Who Do Not Carry The Apoe4 Genotype
08.06.2012
Summertime Shines a Light on the Need for Vitamin D
08.02.2012
Study Shows Toviaz Is Effective In Reducing Urge Urinary Incontinence In Patients With Overactive Bladder After Suboptimal Response To Detrol LA

July 2012

07.31.2012
Pfizer Announces Positive Top-Line Results From The ORAL Start Phase 3 Study Of Tofacitinib In Rheumatoid Arthritis
07.30.2012
Pfizer Reports Second-Quarter 2012 Results
07.23.2012
Pfizer Announces Topline Results Of First Of Four Studies In Bapineuzumab Phase 3 Program

Page 152
Page 153
Current page 154
Page 155
Page 156

Media Resources & Contact Information

Media Contacts
Press Kits

Anyone may view our press releases, press statements, and press kits.

However, to ensure that customers, investors, and others receive the appropriate attention, Pfizer media contacts may only respond to calls and emails from professional journalists.

Investors
Media
Careers
Partners

PfizerForAll
Healthcare Professionals
Grant Seekers
Business to Business

Privacy Statement
Accessibility Statement
Terms of Use
Contact Us

Glossary

© 2025 Pfizer Inc. All rights reserved

This information—including product information—is intended only for residents of the United States.

The products discussed herein may have different labeling in different countries.

Twitter
Facebook
Linked In
Instagram
Youtube